Drug Side Effects

ALBUTEROL SULFATE

ALBUTEROL SULFATE was reported 181151 times

ALBUTEROL SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRODUCT CLEANING INADEQUATE 1841 0.8684
1 INHALATION THERAPY 409 0.6586
2 DEVICE DELIVERY SYSTEM ISSUE 798 0.5320
3 FORCED EXPIRATORY VOLUME DECREASED 725 0.3986
4 FORCED VITAL CAPACITY DECREASED 116 0.3314
5 PEAK EXPIRATORY FLOW RATE DECREASED 110 0.3134
6 DEVICE USE ERROR 4959 0.2476
7 STATUS ASTHMATICUS 105 0.2403
8 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 942 0.2143
9 ASTHMA 11330 0.1962
10 RESPIRATORY TRACT IRRITATION 131 0.1929
11 LOWER RESPIRATORY TRACT CONGESTION 182 0.1902
12 SPUTUM DISCOLOURED 1063 0.1853
13 NASAL POLYPS 235 0.1813
14 BRONCHIAL SECRETION RETENTION 114 0.1812
15 OBSTRUCTIVE AIRWAYS DISORDER 1112 0.1792
16 SPUTUM INCREASED 197 0.1727
17 LUNG HYPERINFLATION 103 0.1720
18 WHEEZING 5383 0.1673
19 TOTAL LUNG CAPACITY DECREASED 152 0.1656
20 BLOOD IMMUNOGLOBULIN E INCREASED 222 0.1615
21 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 112 0.1612
22 PULMONARY FUNCTION TEST DECREASED 486 0.1585
23 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2453 0.1532
24 RHONCHI 150 0.1462
25 NEPHROGENIC ANAEMIA 496 0.1445
26 PULMONARY FUNCTION TEST ABNORMAL 135 0.1442
27 HYPERPARATHYROIDISM SECONDARY 261 0.1437
28 BRONCHIAL HYPERREACTIVITY 118 0.1388
29 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4988 0.1379
30 NASAL DISCHARGE DISCOLOURATION 106 0.1347
31 BREATH SOUNDS ABNORMAL 383 0.1337
32 CYSTIC FIBROSIS 494 0.1272
33 INTENTIONAL DEVICE MISUSE 374 0.1221
34 BRONCHIAL OBSTRUCTION 124 0.1213
35 CHRONIC SINUSITIS 252 0.1199
36 DEVICE MISUSE 156 0.1178
37 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 387 0.1118
38 PRODUCT COMPLAINT 818 0.1085
39 POOR QUALITY DEVICE USED 324 0.1072
40 PULMONARY PAIN 140 0.1065
41 RESPIRATORY SYMPTOM 111 0.1052
42 INCREASED BRONCHIAL SECRETION 145 0.1044
43 PRODUCTIVE COUGH 2803 0.1032
44 REBOUND ACID HYPERSECRETION 270 0.1027
45 SENSITIVITY TO WEATHER CHANGE 265 0.1026
46 RHINITIS ALLERGIC 260 0.1017
47 BRONCHIECTASIS 345 0.1004
48 RALES 377 0.0972
49 EMERGENCY CARE 107 0.0961
50 BRONCHITIS CHRONIC 176 0.0936
51 HYPOVENTILATION 231 0.0917
52 EMPHYSEMA 663 0.0900
53 RHINOVIRUS INFECTION 133 0.0891
54 RESPIRATORY RATE INCREASED 512 0.0871
55 ESSENTIAL HYPERTENSION 152 0.0869
56 VOCAL CORD DISORDER 115 0.0817
57 INCREASED UPPER AIRWAY SECRETION 352 0.0809
58 RESPIRATION ABNORMAL 287 0.0808
59 SECRETION DISCHARGE 530 0.0787
60 ACUTE SINUSITIS 105 0.0776
61 RESPIRATORY TRACT CONGESTION 790 0.0767
62 SEASONAL ALLERGY 525 0.0765
63 BRONCHITIS 4118 0.0765
64 DYSPNOEA EXERTIONAL 1700 0.0763
65 SINUS OPERATION 105 0.0748
66 BRONCHOSPASM 771 0.0741
67 PRE-EXISTING CONDITION IMPROVED 390 0.0733
68 MULTIPLE ALLERGIES 319 0.0730
69 UPPER-AIRWAY COUGH SYNDROME 338 0.0729
70 BILIARY DYSKINESIA 119 0.0726
71 SLEEP APNOEA SYNDROME 960 0.0716
72 PULMONARY CONGESTION 637 0.0715
73 PAINFUL RESPIRATION 126 0.0702
74 PHARYNGEAL ERYTHEMA 111 0.0693
75 ORTHOPNOEA 161 0.0683
76 CANDIDIASIS 274 0.0682
77 DYSPNOEA AT REST 113 0.0667
78 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6514 0.0665
79 LUNG INFECTION 1027 0.0650
80 DYSPHONIA 2407 0.0648
81 BLOOD PRESSURE SYSTOLIC INCREASED 706 0.0646
82 FOOD ALLERGY 222 0.0646
83 SNORING 164 0.0642
84 PARANASAL SINUS DISCOMFORT 122 0.0636
85 APHONIA 539 0.0632
86 LOBAR PNEUMONIA 117 0.0631
87 DYSPNOEA 23382 0.0630
88 BODY TEMPERATURE DECREASED 404 0.0628
89 ORAL CANDIDIASIS 506 0.0622
90 CREPITATIONS 138 0.0618
91 LOWER RESPIRATORY TRACT INFECTION 1594 0.0617
92 DIASTOLIC DYSFUNCTION 125 0.0617
93 ATELECTASIS 444 0.0616
94 CHEST DISCOMFORT 3948 0.0612
95 CHOLECYSTITIS CHRONIC 391 0.0608
96 HYPERCAPNIA 117 0.0602
97 SLEEP TERROR 138 0.0602
98 COUGH 10050 0.0599
99 END STAGE RENAL DISEASE 822 0.0595
100 OXYGEN SATURATION DECREASED 1741 0.0578
101 PULMONARY MASS 507 0.0574
102 ACUTE RESPIRATORY FAILURE 632 0.0565
103 PRODUCT QUALITY ISSUE 6253 0.0565
104 RESPIRATORY DISORDER 1123 0.0563
105 EOSINOPHIL COUNT INCREASED 268 0.0556
106 ASTHMATIC CRISIS 126 0.0555
107 MIDDLE INSOMNIA 658 0.0550
108 RESPIRATORY SYNCYTIAL VIRUS INFECTION 178 0.0540
109 CHRONIC KIDNEY DISEASE 2991 0.0540
110 SINUS CONGESTION 491 0.0537
111 CANDIDA INFECTION 490 0.0536
112 TRICUSPID VALVE INCOMPETENCE 293 0.0533
113 UPPER RESPIRATORY TRACT INFECTION 1619 0.0532
114 RED CELL DISTRIBUTION WIDTH INCREASED 120 0.0527
115 PHARMACEUTICAL PRODUCT COMPLAINT 1366 0.0526
116 INVESTIGATION 160 0.0520
117 LUNG DISORDER 1587 0.0518
118 CHOKING 639 0.0515
119 LARYNGITIS 352 0.0512
120 BLOOD COUNT ABNORMAL 690 0.0505
121 SINUSITIS 3277 0.0503
122 EAR PAIN 628 0.0503
123 RESPIRATORY TRACT INFECTION 788 0.0502
124 DIABETIC NEUROPATHY 197 0.0502
125 CHOKING SENSATION 191 0.0499
126 INFUSION SITE SWELLING 122 0.0496
127 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 913 0.0495
128 THROAT IRRITATION 1378 0.0494
129 NON-CARDIAC CHEST PAIN 128 0.0487
130 HYPOPNOEA 103 0.0485
131 DRY THROAT 321 0.0484
132 INABILITY TO AFFORD MEDICATION 150 0.0483
133 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 124 0.0482
134 RHINITIS 245 0.0480
135 SINUS DISORDER 605 0.0479
136 POST-TRAUMATIC STRESS DISORDER 186 0.0477
137 DEVICE FAILURE 438 0.0474
138 HAEMOPTYSIS 933 0.0468
139 NASAL CONGESTION 1584 0.0468
140 PNEUMONIA 9625 0.0467
141 SPINAL OSTEOARTHRITIS 295 0.0466
142 INTERVERTEBRAL DISC DEGENERATION 317 0.0461
143 EXERCISE TOLERANCE DECREASED 161 0.0460
144 PSEUDOMONAS INFECTION 231 0.0458
145 HYPOXIA 1005 0.0457
146 DEVICE MALFUNCTION 1456 0.0455
147 EXPIRED PRODUCT ADMINISTERED 950 0.0444
148 RESPIRATORY DISTRESS 871 0.0443
149 PRODUCT STORAGE ERROR 982 0.0442
150 RESPIRATORY ACIDOSIS 109 0.0438
151 HYPERLIPIDAEMIA 403 0.0434
152 HIATUS HERNIA 421 0.0433
153 HAEMORRHAGIC ANAEMIA 191 0.0432
154 ILL-DEFINED DISORDER 1070 0.0431
155 DEVICE DEFECTIVE 114 0.0431
156 OTITIS MEDIA 104 0.0430
157 ECONOMIC PROBLEM 604 0.0429
158 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 956 0.0423
159 BURSITIS 284 0.0423
160 MITRAL VALVE INCOMPETENCE 346 0.0422
161 OBESITY 418 0.0421
162 DIVERTICULUM 253 0.0417
163 PNEUMOTHORAX 411 0.0411
164 VIRAL UPPER RESPIRATORY TRACT INFECTION 164 0.0410
165 PULMONARY HYPERTENSION 614 0.0406
166 CARDIOMEGALY 402 0.0405
167 OROPHARYNGEAL PAIN 2322 0.0401
168 TONGUE DISCOLOURATION 139 0.0399
169 SCOLIOSIS 165 0.0399
170 CAROTID ARTERY STENOSIS 108 0.0396
171 PRODUCT TASTE ABNORMAL 322 0.0394
172 LIGAMENT SPRAIN 236 0.0394
173 HEART RATE INCREASED 2543 0.0394
174 INFLUENZA 2670 0.0391
175 PHARYNGOLARYNGEAL PAIN 208 0.0391
176 INTENTIONAL UNDERDOSE 204 0.0390
177 THROMBOPHLEBITIS SUPERFICIAL 115 0.0390
178 CARDIAC MURMUR 265 0.0386
179 RHINORRHOEA 1477 0.0386
180 VITAMIN D DEFICIENCY 236 0.0385
181 CATARACT OPERATION 158 0.0385
182 HYPERVENTILATION 163 0.0382
183 BLOOD PRESSURE DIASTOLIC DECREASED 156 0.0380
184 EAR INFECTION 579 0.0380
185 ABDOMINAL HERNIA 123 0.0380
186 ENURESIS 102 0.0379
187 LEFT VENTRICULAR HYPERTROPHY 116 0.0379
188 MUSCULOSKELETAL CHEST PAIN 387 0.0378
189 PARANASAL SINUS HYPERSECRETION 110 0.0378
190 RIB FRACTURE 505 0.0377
191 VIRAL INFECTION 794 0.0376
192 PERIPHERAL VASCULAR DISORDER 158 0.0375
193 LUNG NEOPLASM 130 0.0374
194 BLOOD IRON DECREASED 236 0.0374
195 NASOPHARYNGITIS 4214 0.0371
196 GASTROOESOPHAGEAL REFLUX DISEASE 1947 0.0371
197 SKIN LACERATION 191 0.0371
198 THROAT TIGHTNESS 671 0.0369
199 BODY HEIGHT DECREASED 317 0.0368
200 BODY TEMPERATURE INCREASED 513 0.0366
201 LUNG NEOPLASM MALIGNANT 719 0.0365
202 UNDERDOSE 1743 0.0363
203 PLEURISY 167 0.0362
204 FEELING JITTERY 516 0.0360
205 WEIGHT FLUCTUATION 185 0.0359
206 SARCOIDOSIS 113 0.0354
207 ASPIRATION 247 0.0354
208 BLOOD MAGNESIUM DECREASED 185 0.0353
209 FIBROMYALGIA 506 0.0351
210 PRODUCT DOSE OMISSION ISSUE 899 0.0351
211 INFUSION SITE ERYTHEMA 128 0.0349
212 SNEEZING 459 0.0348
213 OROPHARYNGEAL DISCOMFORT 122 0.0348
214 LOWER GASTROINTESTINAL HAEMORRHAGE 204 0.0347
215 CONCUSSION 169 0.0346
216 SPINAL OPERATION 171 0.0346
217 OSTEOPENIA 314 0.0343
218 ADRENAL INSUFFICIENCY 195 0.0343
219 PANIC REACTION 174 0.0342
220 FRUSTRATION TOLERANCE DECREASED 135 0.0340
221 SINUS HEADACHE 157 0.0339
222 RENAL INJURY 839 0.0338
223 DECREASED ACTIVITY 199 0.0338
224 HOSPICE CARE 144 0.0337
225 CATARACT 1192 0.0337
226 RETCHING 473 0.0336
227 SOMNAMBULISM 169 0.0336
228 BACK INJURY 216 0.0336
229 DRUG ADMINISTRATION ERROR 1033 0.0336
230 OSTEOARTHRITIS 904 0.0335
231 ABNORMAL LOSS OF WEIGHT 162 0.0335
232 DYSLIPIDAEMIA 108 0.0335
233 POLYP 143 0.0335
234 IMPAIRED GASTRIC EMPTYING 162 0.0335
235 ARTERIOSCLEROSIS 221 0.0333
236 AORTIC VALVE INCOMPETENCE 103 0.0333
237 PRODUCT PHYSICAL ISSUE 384 0.0333
238 RENAL CYST 187 0.0332
239 RESPIRATORY FAILURE 1693 0.0331
240 EAR DISCOMFORT 214 0.0330
241 IRON DEFICIENCY ANAEMIA 207 0.0330
242 MOUTH SWELLING 112 0.0329
243 GLOSSODYNIA 358 0.0329
244 PNEUMONIA BACTERIAL 143 0.0327
245 FAILURE TO THRIVE 129 0.0326
246 MAJOR DEPRESSION 154 0.0324
247 BIPOLAR DISORDER 268 0.0324
248 PHARYNGITIS STREPTOCOCCAL 213 0.0323
249 CHEST PAIN 4279 0.0323
250 PULMONARY THROMBOSIS 205 0.0322
251 MUSCLE SPASTICITY 290 0.0322
252 ARTERIOSCLEROSIS CORONARY ARTERY 151 0.0322
253 INTENTIONAL PRODUCT MISUSE 1789 0.0322
254 OVERWEIGHT 106 0.0321
255 LUNG INFILTRATION 234 0.0321
256 ABDOMINAL TENDERNESS 114 0.0320
257 CATHETERISATION CARDIAC 104 0.0319
258 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 436 0.0319
259 MACULAR DEGENERATION 227 0.0319
260 INTERVERTEBRAL DISC PROTRUSION 499 0.0318
261 GASTROENTERITIS VIRAL 357 0.0316
262 BLOOD POTASSIUM DECREASED 636 0.0315
263 SUPRAVENTRICULAR TACHYCARDIA 214 0.0314
264 HEREDITARY ANGIOEDEMA 162 0.0314
265 GALLBLADDER DISORDER 426 0.0314
266 APPARENT DEATH 111 0.0313
267 BENIGN PROSTATIC HYPERPLASIA 114 0.0312
268 PRODUCT DOSE OMISSION 2142 0.0311
269 OSTEOPOROSIS 795 0.0310
270 MUSCLE STRAIN 178 0.0310
271 GLUCOSE TOLERANCE IMPAIRED 115 0.0309
272 PHARYNGITIS 269 0.0309
273 LIMB INJURY 480 0.0308
274 PHARYNGEAL OEDEMA 458 0.0307
275 NIGHT SWEATS 609 0.0305
276 SINUS TACHYCARDIA 301 0.0305
277 HAND FRACTURE 135 0.0304
278 CHOLECYSTECTOMY 231 0.0301
279 TOOTH ABSCESS 225 0.0301
280 RENAL FAILURE CHRONIC 232 0.0301
281 ORAL PAIN 455 0.0301
282 TACHYPNOEA 245 0.0300
283 ANHEDONIA 556 0.0300
284 ILLNESS 253 0.0299
285 FOOT FRACTURE 381 0.0299
286 DERMATITIS ATOPIC 146 0.0299
287 PULMONARY FIBROSIS 342 0.0298
288 MENISCUS INJURY 116 0.0298
289 ANEURYSM 103 0.0297
290 ORAL DISORDER 148 0.0296
291 CARPAL TUNNEL SYNDROME 273 0.0296
292 SPINAL COLUMN STENOSIS 141 0.0296
293 TEMPERATURE INTOLERANCE 182 0.0295
294 ECZEMA 457 0.0295
295 MEDICATION ERROR 1152 0.0294
296 EYE INFECTION 187 0.0294
297 CARDIAC VALVE DISEASE 121 0.0293
298 HEART RATE IRREGULAR 484 0.0293
299 WRIST FRACTURE 232 0.0292
300 NERVE COMPRESSION 173 0.0292
301 ROTATOR CUFF SYNDROME 266 0.0292
302 RENAL FAILURE 2897 0.0292
303 EXOSTOSIS 176 0.0291
304 ACUTE KIDNEY INJURY 2534 0.0289
305 SCIATICA 257 0.0289
306 CARDIAC FAILURE CONGESTIVE 1976 0.0289
307 MEDICATION RESIDUE PRESENT 138 0.0288
308 ECCHYMOSIS 149 0.0287
309 LEFT VENTRICULAR DYSFUNCTION 127 0.0286
310 GLAUCOMA 368 0.0286
311 WALKING AID USER 115 0.0285
312 RIGHT VENTRICULAR FAILURE 155 0.0283
313 JOINT DISLOCATION 192 0.0283
314 ATRIAL FLUTTER 163 0.0281
315 CHOLELITHIASIS 667 0.0281
316 FLANK PAIN 175 0.0280
317 PARAESTHESIA ORAL 255 0.0280
318 JOINT INJURY 379 0.0280
319 VENTRICULAR EXTRASYSTOLES 214 0.0280
320 SWOLLEN TONGUE 629 0.0279
321 PANIC ATTACK 711 0.0279
322 RESTLESS LEGS SYNDROME 350 0.0279
323 EXPIRED DRUG ADMINISTERED 138 0.0279
324 SCRATCH 144 0.0278
325 TONGUE DISORDER 154 0.0278
326 SPINAL COMPRESSION FRACTURE 168 0.0278
327 BACK DISORDER 302 0.0278
328 STENT PLACEMENT 167 0.0278
329 ATRIAL FIBRILLATION 1754 0.0278
330 HYPERCHOLESTEROLAEMIA 156 0.0277
331 TUBULOINTERSTITIAL NEPHRITIS 327 0.0277
332 IMMUNODEFICIENCY 196 0.0277
333 AORTIC ANEURYSM 161 0.0276
334 DRY MOUTH 1470 0.0276
335 BLOOD SODIUM DECREASED 345 0.0276
336 BLOOD PRESSURE INCREASED 2709 0.0275
337 ANKLE FRACTURE 283 0.0274
338 BOWEL MOVEMENT IRREGULARITY 111 0.0273
339 APNOEA 161 0.0273
340 CARDIAC OPERATION 140 0.0272
341 IRRITABLE BOWEL SYNDROME 313 0.0272
342 CELLULITIS 949 0.0271
343 ANAPHYLACTIC REACTION 877 0.0270
344 DENTAL CARIES 211 0.0270
345 GOUT 317 0.0269
346 PERIPHERAL SWELLING 2289 0.0269
347 FLUID RETENTION 938 0.0269
348 BLOOD TEST ABNORMAL 202 0.0268
349 HAEMATOCRIT DECREASED 407 0.0268
350 ELECTROCARDIOGRAM ABNORMAL 147 0.0268
351 ORAL MUCOSAL BLISTERING 115 0.0267
352 CYANOSIS 302 0.0266
353 NERVOUSNESS 1062 0.0265
354 INJURY 1437 0.0265
355 MUSCULOSKELETAL DISCOMFORT 290 0.0264
356 TYPE 2 DIABETES MELLITUS 621 0.0264
357 INTENTIONAL PRODUCT USE ISSUE 1006 0.0264
358 PULMONARY EMBOLISM 1876 0.0264
359 JOINT EFFUSION 125 0.0264
360 DRUG DOSE OMISSION 4370 0.0263
361 MENTAL STATUS CHANGES 524 0.0262
362 RENAL TUBULAR NECROSIS 170 0.0262
363 ORAL DISCOMFORT 252 0.0262
364 MULTIPLE INJURIES 156 0.0262
365 CYST 210 0.0261
366 INCREASED TENDENCY TO BRUISE 173 0.0261
367 ANXIETY 5066 0.0260
368 DIVERTICULITIS 465 0.0260
369 PULMONARY OEDEMA 798 0.0259
370 CARDIOMYOPATHY 275 0.0259
371 STAPHYLOCOCCAL INFECTION 623 0.0259
372 VITAMIN D DECREASED 151 0.0258
373 DEEP VEIN THROMBOSIS 1328 0.0258
374 NASAL DRYNESS 106 0.0258
375 STRESS 1125 0.0257
376 INFUSION SITE PAIN 152 0.0257
377 FLUID OVERLOAD 361 0.0256
378 CONTUSION 1594 0.0256
379 TROPONIN INCREASED 107 0.0256
380 PLEURAL EFFUSION 1083 0.0256
381 DISABILITY 273 0.0255
382 POOR QUALITY SLEEP 333 0.0255
383 BLOOD ALBUMIN DECREASED 146 0.0253
384 EMOTIONAL DISTRESS 1304 0.0253
385 CLOSTRIDIUM DIFFICILE COLITIS 178 0.0253
386 UPPER LIMB FRACTURE 353 0.0253
387 TENDERNESS 180 0.0252
388 UPPER GASTROINTESTINAL HAEMORRHAGE 316 0.0252
389 WOUND INFECTION 145 0.0251
390 BONE DISORDER 350 0.0251
391 NEPHROPATHY 155 0.0251
392 COAGULOPATHY 304 0.0250
393 GINGIVAL PAIN 136 0.0250
394 CARDIAC PACEMAKER INSERTION 106 0.0250
395 DEVICE ISSUE 1029 0.0250
396 THERMAL BURN 124 0.0250
397 GASTRITIS 455 0.0249
398 PERICARDIAL EFFUSION 366 0.0249
399 PALPITATIONS 1951 0.0247
400 OEDEMA PERIPHERAL 2312 0.0247
401 NASAL DISCOMFORT 138 0.0246
402 TOOTH INFECTION 198 0.0246
403 MIGRAINE 1413 0.0246
404 TREATMENT NONCOMPLIANCE 775 0.0245
405 LEUKOCYTOSIS 298 0.0245
406 BREAST MASS 113 0.0245
407 MALNUTRITION 173 0.0245
408 MALAISE 7533 0.0244
409 TREMOR 2850 0.0243
410 HYPERSENSITIVITY 2902 0.0243
411 ARTHROPOD BITE 116 0.0243
412 HUNGER 170 0.0243
413 PROTHROMBIN TIME PROLONGED 125 0.0243
414 BACTERIAL INFECTION 269 0.0242
415 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 174 0.0241
416 HYSTERECTOMY 133 0.0241
417 CONCOMITANT DISEASE AGGRAVATED 103 0.0240
418 ANGINA UNSTABLE 133 0.0240
419 TENDONITIS 271 0.0240
420 NEUTROPHIL COUNT INCREASED 171 0.0239
421 DIABETES MELLITUS 1303 0.0239
422 WEIGHT DECREASED 4270 0.0239
423 HAIR DISORDER 178 0.0239
424 LIP SWELLING 533 0.0238
425 BACK PAIN 3682 0.0238
426 TOOTH FRACTURE 177 0.0238
427 BLOOD CHOLESTEROL INCREASED 733 0.0237
428 PNEUMONITIS 365 0.0237
429 DYSURIA 608 0.0237
430 VENTRICULAR TACHYCARDIA 270 0.0237
431 IMMUNE SYSTEM DISORDER 192 0.0236
432 ARTHRITIS 1148 0.0234
433 NECK PAIN 865 0.0234
434 SENSATION OF FOREIGN BODY 120 0.0233
435 BRAIN INJURY 149 0.0233
436 CONDITION AGGRAVATED 3675 0.0233
437 EYE PRURITUS 378 0.0233
438 MYOCARDIAL ISCHAEMIA 219 0.0232
439 HEAD INJURY 481 0.0231
440 LARGE INTESTINE POLYP 109 0.0231
441 CORONARY ARTERY DISEASE 600 0.0231
442 DYSPEPSIA 1473 0.0230
443 SLEEP DISORDER 921 0.0229
444 SKIN LESION 389 0.0229
445 SCREAMING 106 0.0229
446 TRANSIENT ISCHAEMIC ATTACK 582 0.0229
447 FEEDING DISORDER 216 0.0228
448 HOSPITALISATION 1807 0.0228
449 KNEE OPERATION 110 0.0228
450 HAEMORRHOIDS 311 0.0228
451 ROAD TRAFFIC ACCIDENT 652 0.0227
452 SPINAL FRACTURE 278 0.0226
453 SCAR 271 0.0226
454 HEART RATE DECREASED 485 0.0225
455 NOCTURIA 166 0.0225
456 GASTROENTERITIS 226 0.0225
457 HEPATIC STEATOSIS 278 0.0225
458 COLITIS ISCHAEMIC 104 0.0225
459 TRANSFUSION 160 0.0224
460 CONJUNCTIVITIS 217 0.0223
461 CORONARY ARTERY OCCLUSION 246 0.0223
462 ANGINA PECTORIS 481 0.0223
463 HYPOTHYROIDISM 420 0.0223
464 URTICARIA 2329 0.0222
465 DEPRESSION 3708 0.0222
466 JOINT RANGE OF MOTION DECREASED 155 0.0222
467 HYPERTENSION 3017 0.0221
468 FUNGAL INFECTION 473 0.0221
469 DYSGEUSIA 1144 0.0220
470 LACERATION 208 0.0220
471 EXTRA DOSE ADMINISTERED 353 0.0220
472 WHITE BLOOD CELL COUNT INCREASED 608 0.0220
473 HAIR COLOUR CHANGES 214 0.0219
474 URINARY TRACT INFECTION 2303 0.0219
475 EYE DISORDER 450 0.0219
476 SMALL INTESTINAL OBSTRUCTION 177 0.0219
477 WEIGHT INCREASED 3124 0.0219
478 EPISTAXIS 1134 0.0218
479 RED BLOOD CELL COUNT DECREASED 386 0.0218
480 PULMONARY HAEMORRHAGE 127 0.0218
481 OEDEMA 780 0.0217
482 PSYCHOMOTOR HYPERACTIVITY 276 0.0217
483 CYSTITIS 481 0.0217
484 DECUBITUS ULCER 126 0.0217
485 KIDNEY INFECTION 265 0.0216
486 FACIAL PAIN 124 0.0216
487 LACRIMATION INCREASED 367 0.0216
488 DEVICE OCCLUSION 106 0.0216
489 JOINT SWELLING 1497 0.0216
490 OESOPHAGITIS 163 0.0216
491 NEPHROLITHIASIS 598 0.0215
492 PAROSMIA 106 0.0215
493 URINE OUTPUT DECREASED 140 0.0215
494 CHOLECYSTITIS 179 0.0215
495 DYSPHAGIA 1331 0.0215
496 BLOOD PRESSURE ABNORMAL 239 0.0215
497 GROIN PAIN 133 0.0215
498 COELIAC DISEASE 140 0.0214
499 NEURALGIA 315 0.0214
500 MUSCLE SPASMS 2676 0.0214
501 LYMPHADENOPATHY 495 0.0214
502 HYPERAESTHESIA 129 0.0213
503 CLOSTRIDIUM DIFFICILE INFECTION 268 0.0213
504 PULMONARY ARTERIAL HYPERTENSION 229 0.0213
505 FALL 4695 0.0213
506 MASS 205 0.0213
507 MUSCULOSKELETAL PAIN 957 0.0212
508 INCORRECT DOSE ADMINISTERED BY DEVICE 149 0.0212
509 HERNIA 248 0.0212
510 WOUND 278 0.0212
511 NIGHTMARE 536 0.0212
512 INITIAL INSOMNIA 135 0.0211
513 MOUTH HAEMORRHAGE 103 0.0211
514 DRUG SCREEN POSITIVE 133 0.0211
515 PARANOIA 268 0.0211
516 INSOMNIA 3912 0.0210
517 ACCIDENT 152 0.0210
518 BLOOD PRESSURE FLUCTUATION 311 0.0210
519 PNEUMONIA ASPIRATION 340 0.0210
520 INCREASED APPETITE 233 0.0209
521 THERAPEUTIC RESPONSE UNEXPECTED 650 0.0209
522 AFFECTIVE DISORDER 102 0.0209
523 EXTRASYSTOLES 110 0.0208
524 BLOOD CALCIUM DECREASED 161 0.0208
525 HYPERSOMNIA 389 0.0208
526 THERAPY INTERRUPTED 115 0.0208
527 EOSINOPHILIA 225 0.0208
528 DIZZINESS POSTURAL 111 0.0208
529 THYROID DISORDER 201 0.0207
530 LOCALISED INFECTION 318 0.0207
531 BLOOD POTASSIUM INCREASED 233 0.0207
532 FEAR 449 0.0206
533 PAIN 7387 0.0205
534 CHILLS 1569 0.0205
535 INTERNAL HAEMORRHAGE 164 0.0205
536 ASTHENIA 5072 0.0205
537 PRODUCT USE ISSUE 2164 0.0205
538 HAIR TEXTURE ABNORMAL 223 0.0204
539 DIABETES MELLITUS INADEQUATE CONTROL 248 0.0204
540 BLOOD UREA INCREASED 273 0.0204
541 LOWER LIMB FRACTURE 228 0.0204
542 DRUG EFFECT DECREASED 1104 0.0204
543 SWELLING FACE 902 0.0203
544 GENERALISED OEDEMA 165 0.0203
545 TOOTHACHE 247 0.0203
546 GASTROINTESTINAL HAEMORRHAGE 1375 0.0203
547 MYOPATHY 120 0.0203
548 SWELLING 1129 0.0203
549 URINARY INCONTINENCE 415 0.0202
550 HEADACHE 8417 0.0202
551 TACHYCARDIA 1187 0.0202
552 HYPOKALAEMIA 599 0.0201
553 SURGERY 631 0.0201
554 RECTAL HAEMORRHAGE 618 0.0201
555 LIMB DISCOMFORT 380 0.0201
556 SALIVARY HYPERSECRETION 132 0.0201
557 AGEUSIA 321 0.0200
558 GASTROINTESTINAL INFECTION 110 0.0200
559 CONSTIPATION 2589 0.0200
560 INFECTION 1697 0.0200
561 DEHYDRATION 1865 0.0199
562 SPLENOMEGALY 159 0.0199
563 ACTIVITIES OF DAILY LIVING IMPAIRED 394 0.0198
564 OVARIAN CYST 151 0.0198
565 SPINAL DISORDER 125 0.0197
566 FEELING DRUNK 110 0.0197
567 DRUG INEFFECTIVE 16041 0.0197
568 BLADDER DISORDER 134 0.0197
569 RENAL PAIN 134 0.0196
570 MICTURITION URGENCY 145 0.0196
571 PRESYNCOPE 312 0.0196
572 QUALITY OF LIFE DECREASED 177 0.0196
573 MUSCLE TIGHTNESS 222 0.0195
574 UNRESPONSIVE TO STIMULI 343 0.0195
575 NERVE INJURY 149 0.0195
576 MEMORY IMPAIRMENT 1755 0.0195
577 KNEE ARTHROPLASTY 212 0.0194
578 COLD SWEAT 239 0.0194
579 MOUTH ULCERATION 255 0.0194
580 HEPATOMEGALY 144 0.0194
581 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 119 0.0193
582 ABDOMINAL PAIN UPPER 2565 0.0193
583 ANGER 496 0.0193
584 OBSESSIVE-COMPULSIVE DISORDER 119 0.0193
585 DIZZINESS 6424 0.0193
586 FULL BLOOD COUNT DECREASED 213 0.0193
587 ARTERIAL OCCLUSIVE DISEASE 114 0.0193
588 SPEECH DISORDER 703 0.0192
589 BURNING SENSATION 927 0.0191
590 TOOTH DISORDER 296 0.0191
591 HEAD DISCOMFORT 195 0.0191
592 FATIGUE 9074 0.0191
593 MENTAL DISORDER 526 0.0191
594 GLOMERULAR FILTRATION RATE DECREASED 120 0.0190
595 VISION BLURRED 1706 0.0190
596 PRURITUS GENERALISED 414 0.0190
597 THIRST 207 0.0190
598 INTERNATIONAL NORMALISED RATIO INCREASED 481 0.0190
599 PAIN IN EXTREMITY 3857 0.0190
600 ELECTROLYTE IMBALANCE 136 0.0189
601 HAEMATEMESIS 346 0.0189
602 POST PROCEDURAL COMPLICATION 261 0.0189
603 RENAL FAILURE ACUTE 803 0.0189
604 FAECES DISCOLOURED 288 0.0188
605 HYPOAESTHESIA 1907 0.0188
606 BLOOD PRESSURE DECREASED 825 0.0187
607 PRESCRIBED OVERDOSE 235 0.0187
608 PYELONEPHRITIS 104 0.0187
609 HYPOACUSIS 432 0.0186
610 HIP FRACTURE 385 0.0186
611 CRYING 521 0.0186
612 EYE SWELLING 449 0.0186
613 NODULE 152 0.0186
614 SKIN INFECTION 121 0.0185
615 CARDIAC DISORDER 1191 0.0185
616 ABNORMAL DREAMS 413 0.0185
617 FEELING ABNORMAL 3131 0.0185
618 PYREXIA 4204 0.0185
619 EYE DISCHARGE 105 0.0185
620 SEPSIS 1385 0.0185
621 MOOD SWINGS 446 0.0185
622 DRY EYE 417 0.0184
623 BLOOD CALCIUM INCREASED 115 0.0184
624 ABDOMINAL DISTENSION 1242 0.0184
625 NEUROPATHY PERIPHERAL 1001 0.0184
626 URINARY RETENTION 405 0.0184
627 POLLAKIURIA 511 0.0184
628 AGGRESSION 698 0.0183
629 UTERINE PERFORATION 133 0.0183
630 RASH ERYTHEMATOUS 495 0.0183
631 HAEMOGLOBIN DECREASED 1292 0.0183
632 SUICIDAL IDEATION 1190 0.0182
633 TENDON RUPTURE 169 0.0182
634 INFUSION RELATED REACTION 593 0.0182
635 LOSS OF CONSCIOUSNESS 1637 0.0182
636 ABSCESS 184 0.0182
637 HYPOPHAGIA 294 0.0182
638 PALLOR 312 0.0182
639 GAIT INABILITY 240 0.0181
640 HYPERHIDROSIS 1632 0.0181
641 ATRIAL SEPTAL DEFECT 121 0.0181
642 PERIPHERAL COLDNESS 169 0.0181
643 SKIN ULCER 313 0.0181
644 EJECTION FRACTION DECREASED 172 0.0181
645 PERICARDITIS 106 0.0181
646 DIARRHOEA HAEMORRHAGIC 111 0.0180
647 LETHARGY 737 0.0180
648 ABDOMINAL PAIN 2747 0.0180
649 AMNESIA 851 0.0180
650 BREAST PAIN 142 0.0179
651 FLATULENCE 663 0.0179
652 BALANCE DISORDER 1063 0.0178
653 HAEMATURIA 449 0.0178
654 HERPES ZOSTER 661 0.0177
655 FEELING COLD 333 0.0177
656 HYPERGLYCAEMIA 445 0.0177
657 HIP ARTHROPLASTY 142 0.0177
658 MUSCULAR WEAKNESS 1365 0.0176
659 MADAROSIS 174 0.0176
660 ARTHRALGIA 4287 0.0176
661 THROMBOSIS 936 0.0176
662 PAIN IN JAW 361 0.0176
663 MYALGIA 2049 0.0175
664 HYPOTENSION 2312 0.0175
665 DRUG DISPENSING ERROR 268 0.0175
666 ACUTE CORONARY SYNDROME 111 0.0175
667 DIPLOPIA 301 0.0175
668 PLATELET COUNT INCREASED 142 0.0175
669 ANOSMIA 169 0.0174
670 STOMATITIS 636 0.0174
671 INCONTINENCE 126 0.0174
672 TOOTH LOSS 214 0.0173
673 VOMITING 5334 0.0173
674 LYMPHOCYTE COUNT DECREASED 193 0.0173
675 INTESTINAL OBSTRUCTION 393 0.0173
676 BACTERAEMIA 118 0.0173
677 DECREASED APPETITE 2435 0.0172
678 GAIT DISTURBANCE 2240 0.0172
679 BLISTER 584 0.0172
680 HAEMATOMA 328 0.0172
681 UNEVALUABLE EVENT 913 0.0171
682 HEARING IMPAIRED 103 0.0171
683 BASAL CELL CARCINOMA 172 0.0171
684 OSTEOMYELITIS 231 0.0171
685 LOCAL SWELLING 299 0.0171
686 SYNCOPE 1186 0.0171
687 PERSONALITY CHANGE 122 0.0170
688 ABDOMINAL DISCOMFORT 1705 0.0170
689 GASTRIC DISORDER 480 0.0170
690 JOINT STIFFNESS 292 0.0170
691 DISCOMFORT 513 0.0170
692 HYPOAESTHESIA ORAL 176 0.0170
693 ANAEMIA 2213 0.0169
694 THERAPY CESSATION 523 0.0169
695 EYE PAIN 532 0.0169
696 DERMATITIS CONTACT 121 0.0169
697 INFLUENZA LIKE ILLNESS 1047 0.0169
698 TOOTH EXTRACTION 147 0.0169
699 ACUTE MYOCARDIAL INFARCTION 380 0.0168
700 HYPERKALAEMIA 400 0.0168
701 DEPRESSED MOOD 565 0.0168
702 SKIN CANCER 152 0.0168
703 BLOOD URINE PRESENT 227 0.0168
704 NAUSEA 8657 0.0167
705 THERAPEUTIC RESPONSE DECREASED 633 0.0167
706 THINKING ABNORMAL 235 0.0167
707 PRODUCT USE IN UNAPPROVED INDICATION 1685 0.0166
708 RASH PRURITIC 559 0.0166
709 INCORRECT PRODUCT STORAGE 218 0.0166
710 PRURITUS 3460 0.0166
711 EATING DISORDER 233 0.0165
712 ULCER 174 0.0165
713 DYSARTHRIA 441 0.0165
714 VISUAL IMPAIRMENT 1192 0.0165
715 FOOT DEFORMITY 116 0.0165
716 SCAB 119 0.0164
717 ARTHROPATHY 545 0.0164
718 FEELING HOT 669 0.0164
719 CONFUSIONAL STATE 1833 0.0164
720 CHROMATURIA 266 0.0164
721 HYPOKINESIA 161 0.0164
722 SKIN DISCOLOURATION 505 0.0164
723 HAEMATOCHEZIA 505 0.0162
724 INFLAMMATION 452 0.0162
725 IMPAIRED WORK ABILITY 255 0.0162
726 DIARRHOEA 6329 0.0161
727 MUSCLE ATROPHY 126 0.0161
728 ORAL HERPES 181 0.0161
729 PHOTOPHOBIA 184 0.0161
730 TINNITUS 501 0.0161
731 MULTIPLE FRACTURES 113 0.0160
732 ABNORMAL BEHAVIOUR 517 0.0160
733 MOBILITY DECREASED 705 0.0159
734 ERUCTATION 171 0.0159
735 SOMNOLENCE 2140 0.0159
736 HALLUCINATION 746 0.0159
737 VERTIGO 674 0.0158
738 ARRHYTHMIA 536 0.0158
739 GASTRIC ULCER 217 0.0158
740 HEPATIC CIRRHOSIS 185 0.0158
741 GINGIVAL BLEEDING 137 0.0158
742 PARAESTHESIA 1704 0.0157
743 INCORRECT DOSE ADMINISTERED 1618 0.0157
744 APHASIA 332 0.0157
745 MUSCULOSKELETAL STIFFNESS 856 0.0157
746 BLOOD TRIGLYCERIDES INCREASED 210 0.0157
747 MUSCLE TWITCHING 255 0.0157
748 HOT FLUSH 695 0.0156
749 BLOOD ALKALINE PHOSPHATASE INCREASED 303 0.0156
750 PELVIC PAIN 205 0.0155
751 BEDRIDDEN 138 0.0155
752 RENAL DISORDER 470 0.0155
753 SKIN DISORDER 299 0.0155
754 DISTURBANCE IN ATTENTION 590 0.0154
755 RESPIRATORY ARREST 349 0.0154
756 BONE PAIN 616 0.0154
757 LIVER FUNCTION TEST ABNORMAL 371 0.0154
758 DEMENTIA 240 0.0153
759 PETECHIAE 110 0.0153
760 IMPAIRED HEALING 312 0.0153
761 ORTHOSTATIC HYPOTENSION 175 0.0153
762 HALLUCINATION, VISUAL 195 0.0153
763 PRODUCT SUBSTITUTION ISSUE 610 0.0153
764 EMOTIONAL DISORDER 347 0.0153
765 VENTRICULAR FIBRILLATION 123 0.0152
766 IRRITABILITY 689 0.0152
767 HEMIPARESIS 193 0.0152
768 MOOD ALTERED 286 0.0151
769 DYSSTASIA 295 0.0151
770 RASH 3937 0.0151
771 ANOREXIA 194 0.0150
772 IMPAIRED DRIVING ABILITY 127 0.0150
773 DISORIENTATION 446 0.0150
774 MOVEMENT DISORDER 330 0.0149
775 SEPTIC SHOCK 402 0.0149
776 SKIN FISSURES 121 0.0148
777 LACTIC ACIDOSIS 278 0.0148
778 HYPOMAGNESAEMIA 120 0.0147
779 GASTROINTESTINAL DISORDER 672 0.0147
780 MENTAL IMPAIRMENT 245 0.0147
781 LIVER FUNCTION TEST INCREASED 158 0.0147
782 PSYCHOLOGICAL TRAUMA 116 0.0147
783 AGITATION 804 0.0146
784 CONTRAINDICATED PRODUCT ADMINISTERED 200 0.0146
785 MYOCARDIAL INFARCTION 2101 0.0146
786 GENERAL PHYSICAL HEALTH DETERIORATION 936 0.0146
787 PANCREATITIS 551 0.0145
788 ABASIA 359 0.0145
789 ANAPHYLACTIC SHOCK 231 0.0145
790 BLOOD CREATININE INCREASED 655 0.0145
791 ADVERSE DRUG REACTION 653 0.0144
792 LYMPHOMA 137 0.0144
793 ATAXIA 123 0.0144
794 DRUG HYPERSENSITIVITY 1965 0.0144
795 DERMATITIS 172 0.0143
796 ENCEPHALOPATHY 223 0.0143
797 PANCREATITIS ACUTE 211 0.0143
798 COVID-19 175 0.0142
799 HALLUCINATION, AUDITORY 151 0.0142
800 DRUG EFFECT INCOMPLETE 521 0.0142
801 SENSORY DISTURBANCE 174 0.0142
802 CARDIAC ARREST 845 0.0142
803 PHOTOSENSITIVITY REACTION 157 0.0141
804 PARALYSIS 140 0.0141
805 VISUAL ACUITY REDUCED 400 0.0141
806 HYPONATRAEMIA 544 0.0140
807 HEPATIC ENZYME INCREASED 557 0.0140
808 FACE OEDEMA 170 0.0139
809 OVERDOSE 1670 0.0139
810 PROCEDURAL PAIN 238 0.0139
811 DEAFNESS 229 0.0139
812 FREQUENT BOWEL MOVEMENTS 190 0.0139
813 BLINDNESS 351 0.0138
814 DIALYSIS 146 0.0138
815 CARDIAC FAILURE 729 0.0138
816 HYPOGLYCAEMIA 484 0.0138
817 BONE DENSITY DECREASED 250 0.0138
818 METABOLIC ACIDOSIS 267 0.0138
819 INTENTIONAL DRUG MISUSE 289 0.0138
820 OCULAR HYPERAEMIA 364 0.0137
821 HYPERCALCAEMIA 110 0.0137
822 RHEUMATOID ARTHRITIS 914 0.0137
823 SYSTEMIC LUPUS ERYTHEMATOSUS 211 0.0136
824 ABDOMINAL PAIN LOWER 243 0.0136
825 ASPARTATE AMINOTRANSFERASE INCREASED 523 0.0136
826 DISEASE RECURRENCE 205 0.0135
827 SEIZURE 836 0.0135
828 ANGIOEDEMA 394 0.0135
829 RASH MACULAR 285 0.0134
830 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 666 0.0134
831 COLON CANCER 122 0.0134
832 DYSKINESIA 375 0.0134
833 CARDIOGENIC SHOCK 110 0.0133
834 ACUTE RESPIRATORY DISTRESS SYNDROME 157 0.0133
835 RESTLESSNESS 339 0.0133
836 PLASMA CELL MYELOMA 294 0.0132
837 COLITIS 279 0.0132
838 SUDDEN DEATH 110 0.0131
839 CEREBROVASCULAR ACCIDENT 1641 0.0131
840 NEOPLASM MALIGNANT 453 0.0130
841 ERYTHEMA 1788 0.0130
842 LABORATORY TEST ABNORMAL 243 0.0130
843 METASTASES TO BONE 118 0.0130
844 BLOOD BILIRUBIN INCREASED 257 0.0129
845 NO THERAPEUTIC RESPONSE 157 0.0129
846 BLINDNESS UNILATERAL 122 0.0128
847 BRADYCARDIA 473 0.0128
848 ILEUS 106 0.0128
849 BLOOD GLUCOSE FLUCTUATION 102 0.0128
850 COORDINATION ABNORMAL 143 0.0128
851 EYE HAEMORRHAGE 119 0.0127
852 DEVICE RELATED INFECTION 144 0.0126
853 PRODUCT PRESCRIBING ERROR 106 0.0126
854 MALIGNANT MELANOMA 113 0.0126
855 ALANINE AMINOTRANSFERASE INCREASED 554 0.0125
856 INTRAOCULAR PRESSURE INCREASED 115 0.0125
857 THERAPEUTIC PRODUCT EFFECT DECREASED 183 0.0123
858 DRUG PRESCRIBING ERROR 237 0.0123
859 RASH GENERALISED 320 0.0123
860 MUSCULOSKELETAL DISORDER 163 0.0122
861 CARDIO-RESPIRATORY ARREST 389 0.0122
862 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 874 0.0122
863 GLYCOSYLATED HAEMOGLOBIN INCREASED 186 0.0121
864 ASCITES 241 0.0121
865 FLUSHING 927 0.0121
866 RASH PAPULAR 199 0.0121
867 POST PROCEDURAL HAEMORRHAGE 104 0.0121
868 INCORRECT ROUTE OF DRUG ADMINISTRATION 430 0.0120
869 OFF LABEL USE 4545 0.0120
870 RENAL IMPAIRMENT 601 0.0120
871 DYSMENORRHOEA 109 0.0119
872 PSORIATIC ARTHROPATHY 218 0.0119
873 DRUG EXPOSURE DURING PREGNANCY 406 0.0119
874 ADVERSE EVENT 747 0.0119
875 MELAENA 188 0.0119
876 DELIRIUM 257 0.0118
877 ALOPECIA 1562 0.0118
878 MANIA 141 0.0117
879 SEDATION 184 0.0117
880 DELUSION 118 0.0117
881 CIRCULATORY COLLAPSE 151 0.0117
882 PSYCHOTIC DISORDER 245 0.0117
883 WITHDRAWAL SYNDROME 305 0.0117
884 BLOOD GLUCOSE ABNORMAL 140 0.0116
885 MULTI-ORGAN FAILURE 202 0.0116
886 CONVULSION 663 0.0116
887 COGNITIVE DISORDER 342 0.0115
888 DRUG INTOLERANCE 618 0.0114
889 HAEMORRHAGE 772 0.0114
890 WHITE BLOOD CELL COUNT DECREASED 746 0.0113
891 BLOOD GLUCOSE DECREASED 393 0.0111
892 HEPATIC FAILURE 241 0.0111
893 COMA 367 0.0110
894 SKIN EXFOLIATION 548 0.0110
895 SUBDURAL HAEMATOMA 118 0.0110
896 PLATELET COUNT DECREASED 723 0.0110
897 DISEASE PROGRESSION 707 0.0109
898 HYPOCALCAEMIA 135 0.0109
899 BLOOD CREATINE PHOSPHOKINASE INCREASED 246 0.0109
900 PROSTATE CANCER 184 0.0109
901 ELECTROCARDIOGRAM QT PROLONGED 247 0.0108
902 THROMBOCYTOPENIA 750 0.0106
903 THERAPY NON-RESPONDER 197 0.0104
904 COLITIS ULCERATIVE 197 0.0103
905 MENORRHAGIA 201 0.0103
906 LIVER DISORDER 290 0.0102
907 DRY SKIN 775 0.0102
908 PROTEINURIA 113 0.0102
909 ACCIDENTAL OVERDOSE 236 0.0102
910 BLOOD GLUCOSE INCREASED 1383 0.0101
911 DEPRESSED LEVEL OF CONSCIOUSNESS 268 0.0101
912 WRONG TECHNIQUE IN DRUG USAGE PROCESS 366 0.0101
913 DRUG INTERACTION 1081 0.0099
914 C-REACTIVE PROTEIN INCREASED 212 0.0099
915 EXPOSURE DURING PREGNANCY 354 0.0099
916 INJECTION SITE RASH 179 0.0098
917 PRESCRIBED UNDERDOSE 108 0.0098
918 PANCYTOPENIA 352 0.0098
919 EYE IRRITATION 292 0.0097
920 INTENTIONAL OVERDOSE 382 0.0097
921 SUICIDE ATTEMPT 402 0.0097
922 FRACTURE 135 0.0096
923 FEMUR FRACTURE 226 0.0096
924 DEVICE LEAKAGE 107 0.0094
925 OSTEONECROSIS OF JAW 186 0.0094
926 INJECTION SITE URTICARIA 133 0.0094
927 DRUG WITHDRAWAL SYNDROME 435 0.0093
928 ERECTILE DYSFUNCTION 154 0.0092
929 INTERSTITIAL LUNG DISEASE 274 0.0092
930 OSTEONECROSIS 211 0.0092
931 BREAST CANCER 348 0.0091
932 DEVICE BREAKAGE 129 0.0091
933 STEVENS-JOHNSON SYNDROME 153 0.0091
934 INJECTION SITE BRUISING 456 0.0091
935 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 251 0.0090
936 DIABETIC KETOACIDOSIS 146 0.0090
937 TRANSAMINASES INCREASED 136 0.0090
938 PREGNANCY 149 0.0090
939 INJECTION SITE PRURITUS 405 0.0090
940 DEVICE DIFFICULT TO USE 113 0.0090
941 HEPATITIS 154 0.0089
942 JAUNDICE 184 0.0088
943 PSORIASIS 701 0.0087
944 MULTIPLE SCLEROSIS RELAPSE 440 0.0086
945 RHABDOMYOLYSIS 252 0.0086
946 DRUG TOXICITY 117 0.0086
947 VAGINAL HAEMORRHAGE 287 0.0086
948 INJECTION SITE HAEMATOMA 114 0.0086
949 RASH MACULO-PAPULAR 119 0.0085
950 NERVOUS SYSTEM DISORDER 207 0.0084
951 INJECTION SITE MASS 180 0.0083
952 INJECTION SITE SWELLING 389 0.0083
953 DEATH 4358 0.0082
954 CARDIOVASCULAR DISORDER 177 0.0082
955 SHOCK 122 0.0082
956 MULTIPLE SCLEROSIS 257 0.0081
957 FEBRILE NEUTROPENIA 310 0.0081
958 DEVICE DISLOCATION 228 0.0079
959 INJECTION SITE PAIN 1404 0.0079
960 INJECTION SITE ERYTHEMA 676 0.0078
961 DRUG DEPENDENCE 413 0.0078
962 CEREBRAL HAEMORRHAGE 198 0.0077
963 PAIN OF SKIN 142 0.0077
964 DYSTONIA 116 0.0076
965 NEUTROPENIA 556 0.0076
966 ABORTION SPONTANEOUS 221 0.0076
967 ACCIDENTAL EXPOSURE TO PRODUCT 274 0.0076
968 NEUTROPHIL COUNT DECREASED 168 0.0075
969 GAMMA-GLUTAMYLTRANSFERASE INCREASED 128 0.0075
970 LEUKOPENIA 243 0.0074
971 TARDIVE DYSKINESIA 177 0.0073
972 NEOPLASM PROGRESSION 138 0.0071
973 INJECTION SITE HAEMORRHAGE 329 0.0071
974 EPILEPSY 130 0.0070
975 INJECTION SITE WARMTH 111 0.0069
976 MATERNAL EXPOSURE DURING PREGNANCY 280 0.0068
977 INJECTION SITE REACTION 322 0.0068
978 ACNE 361 0.0067
979 MALIGNANT NEOPLASM PROGRESSION 354 0.0061
980 METRORRHAGIA 103 0.0061
981 PRODUCT ADHESION ISSUE 120 0.0059
982 CEREBRAL INFARCTION 103 0.0059
983 INCORRECT DRUG ADMINISTRATION DURATION 163 0.0058
984 PREMATURE BABY 117 0.0057
985 NO ADVERSE EVENT 449 0.0054
986 MENSTRUATION IRREGULAR 117 0.0053
987 BLADDER CANCER 109 0.0053
988 EXTRAPYRAMIDAL DISORDER 106 0.0049
989 SKIN BURNING SENSATION 240 0.0048
990 SKIN IRRITATION 143 0.0045
991 FOETAL EXPOSURE DURING PREGNANCY 191 0.0040
992 TOXICITY TO VARIOUS AGENTS 401 0.0039
993 TREATMENT FAILURE 171 0.0037
994 DRUG ABUSE 156 0.0030
995 COMPLETED SUICIDE 158 0.0025
996 DEVICE EXPULSION 103 0.0021